Level A Evidence

4 Treatment Options Available

Liver Cancer Treatment

Q: What are the Milan criteria for liver transplant?

Milan criteria for HCC: Single tumor ≤5cm, or up to 3 tumors each ≤3cm, no vascular invasion, no extrahepatic spread. Patients meeting criteria have 70%+ 5-year survival after transplant.

Q: Is living donor liver transplant available?

Yes. China has extensive experience with living donor liver transplantation. Donor safety is paramount—extensive evaluation ensures donor can safely donate a portion of liver.

Q: What is the recurrence rate after liver resection for HCC?

5-year recurrence rate is 50-70% for HCC after resection, highlighting the importance of surveillance. Surveillance protocol includes imaging and AFP every 3 months.

Q: Can I receive immunotherapy for liver cancer?

Yes. Atezolizumab + bevacizumab combination is standard first-line for advanced HCC. Multiple immunotherapy options and clinical trials are available.

Q: What is liver cancer treatment China cost for resection or ablation?

Liver cancer treatment China cost for resection starts from approximately $15,000; ablation from $3,000 per session; TACE from $2,000 per session—typically 40-70% lower than in the US. Liver transplant packages are also significantly lower.

HCC & Liver Tumors: Resection, Ablation & Transplantation

Liver cancer treatment requires specialized hepatobiliary expertise. China has some of the world's largest liver surgery and transplant programs. Our partners offer anatomical resection, laparoscopic approaches, microwave ablation, TACE/TARE, and comprehensive care for both primary and metastatic liver tumors.

Condition Overview

Conditions We Treat

Hepatocellular Carcinoma (HCC)Intrahepatic CholangiocarcinomaLiver MetastasesBenign Liver TumorsLiver Transplantation

Core Technologies

适宜人群

•Complex liver resection requiring vascular reconstruction
•Recurrent HCC after previous treatment
•Need for liver transplantation (meeting Milan criteria)
•Multiple liver metastases requiring two-stage approach
•Access to combination targeted/immunotherapy

High-volume hepatobiliary centers with transplant capability

建议在本地考虑

•Small HCC (<3cm) amenable to local ablation
•Standard TACE procedures
•Stable surveillance phase
•Cases with experienced local hepatobiliary surgeon

Straightforward cases with good local expertise

Evidence: Partner centers >1,000 liver resections/year; 5-year survival 70%+ for resectable HCC; liver transplant 5-year survival >75%.

Treatment Options

Liver Resection for HCC

手术

适合：Resectable HCC with preserved liver function

技术：Anatomical resection, laparoscopic or open, with low CVP technique

优势：Best long-term survival for resectable HCC

7-10 daysFrom $12,000

>1,000 liver resections/year at top centers

Tumor Ablation (MWA/RFA)

介入

适合：Small HCC (<3cm), few lesions, poor surgical candidate

技术：Microwave or radiofrequency ablation, laparoscopic or percutaneous

优势：Minimally invasive, preserves liver parenchyma

2-3 daysFrom $3,000

High-volume ablation centers

TACE (Transarterial Chemoembolization)

介入

适合：Intermediate-stage HCC (BCLC B), bridge to transplant

技术：Drug-eluting bead TACE, conventional TACE

优势：Controls tumor growth, palliative and curative intent

2-3 days per sessionFrom $2,000/session

Standard procedure at liver centers

Liver Transplantation

手术

适合：HCC within Milan criteria, end-stage liver disease

技术：Deceased or living donor liver transplant

优势：Definitive treatment for cirrhosis and HCC

14-21 daysFrom $60,000

Asia's largest liver transplant programs

费用对比

Liver Resection for HCC

US Hospital$75,000

UK Private$58,000

MediLink China$15,000

Save 80% vs US • Includes: surgery, 7-10 day stay, standard post-op care

计算费用

治疗流程

Evaluation• Week 1

Multiphasic CT or MRI liver
AFP and liver function tests
Assessment of liver function (Child-Pugh, MELD)
Transplant evaluation (if criteria met)

Treatment• Week 2-4

Surgery: resection, ablation, or transplant
ICU monitoring post-op
Liver function monitoring
Complication management if needed

Surveillance• Years 1-5

CT/MRI every 3 months (HCC surveillance)
AFP monitoring
Antiviral therapy for hepatitis
Lifestyle modification counseling

Clinical Outcomes

5-Year Survival (Resection)

70%

resectable HCC

5-Year Survival (Transplant)

75%

Milan criteria

Post-op Mortality

<1%

liver resection

Complete Ablation Rate

95%

tumors <3cm

常见问题

What are the Milan criteria for liver transplant?

Milan criteria for HCC: Single tumor ≤5cm, or up to 3 tumors each ≤3cm, no vascular invasion, no extrahepatic spread. Patients meeting criteria have 70%+ 5-year survival after transplant.

Is living donor liver transplant available?

Yes. China has extensive experience with living donor liver transplantation. Donor safety is paramount—extensive evaluation ensures donor can safely donate a portion of liver.

What is the recurrence rate after liver resection for HCC?

5-year recurrence rate is 50-70% for HCC after resection, highlighting the importance of surveillance. Surveillance protocol includes imaging and AFP every 3 months.

Can I receive immunotherapy for liver cancer?

Yes. Atezolizumab + bevacizumab combination is standard first-line for advanced HCC. Multiple immunotherapy options and clinical trials are available.

What is liver cancer treatment China cost for resection or ablation?

Liver cancer treatment China cost for resection starts from approximately $15,000; ablation from $3,000 per session; TACE from $2,000 per session—typically 40-70% lower than in the US. Liver transplant packages are also significantly lower.